Amarin Announces Market Introduction of Vascepa® (icosapent ethyl) Capsules for the Treatment of Very High Triglycerides (VHTG) by longitudeadmin | Jan 24, 2013 | Portfolio News
Precision Therapeutics and Med BioGene Announce Successful Completion of LungExpress Dx(TM) Clinical Studies; Precision Therapeutics Prepares for Commercial Launch by longitudeadmin | Jan 23, 2013 | Portfolio News
Amarin Announces First Notification of U.S. Patent Allowance Based on ANCHOR Clinical Trial Results by longitudeadmin | Jan 23, 2013 | Portfolio News
Amarin Announces Publication of Additional Inflammatory Marker Data From MARINE and ANCHOR Phase 3 Clinical Trials in the American Journal of Cardiovascular Drugs by longitudeadmin | Jan 22, 2013 | Portfolio News
Vivatia’s Brightening Complex with Two Percent Hydroquinone Matches Performance of a Four Percent Product by longitudeadmin | Jan 17, 2013 | Portfolio News
